OPAL Fuels Inc. (OPAL)

G1 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29.27	24.31	38.35	40.39	39.31	12.82
Short-Term Investments	-	-	9.88	64.98	-	-
Cash & Short-Term Investments	29.42	24.31	48.22	105.37	39.31	12.82
Cash Growth	6.60%	-49.59%	-54.23%	168.02%	206.59%	18.13%
Accounts Receivable	65.14	57.61	53.11	53.28	33.88	27.53
Other Receivables	3.26	5.64	5.35	4.14	2.39	2.28
Receivables	69.98	64.01	58.45	57.42	36.27	29.8
Inventory	13	10.29	10.19	7.31	5.14	4.24
Prepaid Expenses	9.4	11.05	6.01	7.63	5.48	2.98
Restricted Cash	0.98	0.97	4.4	32.4	-	-
Other Current Assets	0.7	6.55	0.81	1.86	0.77	1.36
Total Current Assets	123.49	117.19	128.07	211.98	86.98	51.21
Property, Plant & Equipment	477.06	470.99	351.79	309.07	169.77	79.49
Long-Term Investments	224.58	223.59	207.1	52.72	47.15	25.57
Goodwill	54.61	54.61	54.61	54.61	54.61	3.45
Other Intangible Assets	-	1.33	1.6	2.17	2.86	3.44
Long-Term Deferred Charges	-	-	-	3.01	2.37	-
Other Long-Term Assets	25.8	10.86	9.13	9.36	6.25	6.3
Total Assets	905.54	881.08	754.61	644.86	380.84	169.46
Accounts Payable	27.62	23.87	20.09	23.18	12.58	8.68
Accrued Expenses	51.91	50.06	42.39	34.19	22.37	15.35
Current Portion of Long-Term Debt	8.06	12.62	1.61	79.47	96.01	12.23
Current Portion of Leases	1.61	3.36	2.04	1.08	-	-
Current Unearned Revenue	8.63	9.28	6.31	8.01	9.79	4.68
Other Current Liabilities	0.4	4.41	1.9	6.98	1.37	1.93
Total Current Liabilities	98.23	103.6	74.34	152.91	142.12	42.86
Long-Term Debt	313.38	285	196.54	88.31	134.08	91.6
Long-Term Leases	12.01	19.71	19.21	12.07	-	-
Other Long-Term Liabilities	8.67	7.73	7.03	13.75	9.69	4.54
Total Liabilities	432.29	416.05	297.12	267.04	285.89	139
Common Stock	0.02	0.02	0.02	0.02	0.01	49.17
Retained Earnings	-13.44	-137	-467.2	-800.81	-	-25.4
Treasury Stock	-11.61	-11.61	-11.61	-	-	-
Comprehensive Income & Other	0	0.15	-0.02	0.2	-	-
Total Common Equity	-25.04	-148.45	-478.81	-800.6	0.01	23.77
Minority Interest	498.28	613.48	936.29	1,178	94.94	6.69
Shareholders' Equity	473.25	465.03	457.49	377.82	94.96	30.46
Total Liabilities & Equity	905.54	881.08	754.61	644.86	380.84	169.46
Total Debt	335.06	320.7	219.4	180.93	230.1	103.83
Net Cash (Debt)	-305.64	-296.39	-171.18	-75.56	-190.78	-91
Net Cash Per Share	-10.81	-10.70	-6.23	-2.90	-	-
Filing Date Shares Outstanding	29	28.43	28.08	27.69	-	-
Total Common Shares Outstanding	29	28.43	28.07	29.48	-	-
Working Capital	25.25	13.59	53.73	59.08	-55.14	8.34
Book Value Per Share	-0.86	-5.22	-17.06	-27.16	-	-
Tangible Book Value	-79.65	-204.39	-535.02	-857.38	-57.46	16.88
Tangible Book Value Per Share	-2.75	-7.19	-19.06	-29.09	-	-
Land	-	1.3	1.3	1.3	1.3	-
Buildings	-	2.59	2.59	2.59	2.54	-
Machinery	-	390.87	260.21	238.73	191.51	-
Construction In Progress	-	169.57	175.06	152.11	62.62	-
Leasehold Improvements	-	0.82	0.82	0.82	0.82	-
Order Backlog	-	66.38	-	-	-	-

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q